Education
About Us
Working with TipRanks
Follow Us
Pliant Therapeutics (PLRX)
NASDAQ:PLRX
PLRX Analyst Ratings
Hold
0 Buy
3 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PLRX Stock 12 Month Forecast
Average Price Target
$3.00
▲(143.90% Upside)
| Highest Price Target$4.00 | Average Price Target$3.00 | Lowest Price Target$2.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
J.P. Morgan
―
Sell
―
Reiterated
12/04/25
Canaccord Genuity
$4
Hold
225.20%
Upside
Reiterated
11/10/25
Needham
―
Hold
―
Reiterated
11/07/25
RBC Capital
$2
Hold
62.60%
Upside
Reiterated
11/06/25
Citi
$1.5→$1.7
Hold
38.21%
Upside
Reiterated
08/11/25
Piper Sandler
$17→$4
Buy
225.20%
Upside
Reiterated
08/08/25
Oppenheimer
―
Hold
―
Reiterated
08/08/25
Leerink Partners
$2
Hold
62.60%
Upside
Reiterated
08/07/25
Westpark Capital
―
Hold
―
Reiterated
03/18/25
Wells Fargo
$4→$3
Hold
143.90%
Upside
Reiterated
03/04/25
Stifel Nicolaus
$32→$3
Hold
143.90%
Upside
Downgraded
03/03/25
Cantor Fitzgerald
―
Hold
―
Initiated
03/03/25
TD Cowen
―
Buy
―
Reiterated
02/18/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
J.P. Morgan
―
Sell
―
Reiterated
12/04/25
Canaccord Genuity
$4
Hold
225.20%
Upside
Reiterated
11/10/25
Needham
―
Hold
―
Reiterated
11/07/25
RBC Capital
$2
Hold
62.60%
Upside
Reiterated
11/06/25
Citi
$1.5→$1.7
Hold
38.21%
Upside
Reiterated
08/11/25
Piper Sandler
$17→$4
Buy
225.20%
Upside
Reiterated
08/08/25
Oppenheimer
―
Hold
―
Reiterated
08/08/25
Leerink Partners
$2
Hold
62.60%
Upside
Reiterated
08/07/25
Westpark Capital
―
Hold
―
Reiterated
03/18/25
Wells Fargo
$4→$3
Hold
143.90%
Upside
Reiterated
03/04/25
Stifel Nicolaus
$32→$3
Hold
143.90%
Upside
Downgraded
03/03/25
Cantor Fitzgerald
―
Hold
―
Initiated
03/03/25
TD Cowen
―
Buy
―
Reiterated
02/18/25
Best Analysts Covering Pliant Therapeutics
1 Month
xxx
Success Rate
8/15 ratings generated profit
Average Return
-6.85%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 53.33% of your transactions generating a profit, with an average return of -6.85% per trade.
3 Months
xxx
Success Rate
7/15 ratings generated profit
Average Return
-6.56%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 46.67% of your transactions generating a profit, with an average return of -6.56% per trade.
1 Year
Success Rate
1/10 ratings generated profit
Average Return
-61.53%
reiterated a buy rating 10 months ago
Copying Ritu Baral's trades and holding each position for 1 Year would result in 10.00% of your transactions generating a profit, with an average return of -61.53% per trade.
2 Years
xxx
Success Rate
0/15 ratings generated profit
Average Return
-71.47%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -71.47% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PLRX Analyst Recommendation Trends
Rating
Jun 25
Aug 25
Oct 25
Nov 25
Dec 25
Strong Buy
1
2
1
1
0
Buy
0
0
0
0
0
Hold
7
12
7
8
3
Sell
2
1
2
2
3
Strong Sell
0
0
0
0
0
total
10
15
10
11
6
Each month's total comprises the sum of three months' worth of ratings.
PLRX Financial Forecast
PLRX Stock Forecast FAQ
What is PLRX’s average 12-month price target, according to analysts?
Based on analyst ratings, Pliant Therapeutics’s 12-month average price target is 3.00.
What is PLRX’s upside potential, based on the analysts’ average price target?
Pliant Therapeutics has 143.90% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PLRX a Buy, Sell or Hold?
Pliant Therapeutics has a consensus rating of Hold which is based on 0 buy ratings, 3 hold ratings and 1 sell ratings.
What is Pliant Therapeutics’s price target?
The average price target for Pliant Therapeutics is 3.00. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $4.00 ,the lowest forecast is $2.00. The average price target represents 143.90% Increase from the current price of $1.23.
The highest analyst price target is $4.00 ,the lowest forecast is $2.00. The average price target represents 143.90% Increase from the current price of $1.23.
What do analysts say about Pliant Therapeutics?
Pliant Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of PLRX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.